Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03042975 · ClinicalTrials.gov registry record

Imaging Genetics of Laryngeal Dystonia

A clinical trial of Laryngeal Dystonia and Muscle Tension Dysphonia, sponsored by Kristina Simonyan.

Recruiting
Registry status
410
Enrollment target
1
Study location

NCT03042975: Recruiting study of Laryngeal Dystonia and Muscle Tension Dysphonia, sponsored by Kristina Simonyan.

NCT03042975 is a study of Laryngeal Dystonia and Muscle Tension Dysphonia that is actively recruiting participants, run by Kristina Simonyan. The registered enrollment target is 410 participants, above the 64-participant average among 9 other Laryngeal Dystonia trials with a reported enrollment target (541% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03042975, a study of Laryngeal Dystonia and Muscle Tension Dysphonia, is actively recruiting participants, sponsored by Kristina Simonyan.

RECRUITING
Registry status
410 participants
Enrollment target
1
Study location

Study Summary

The contribution of genetic risk factors to the development of focal dystonias is evident. However, understanding of how variations in the causative gene expression lead to variations in brain abnormalities in different phenotypes of dystonia (e.g., familial, sporadic) remains limited. The research program of the investigators is set to determine the relationship between brain changes and genetic risk factors in laryngeal dystonia (or spasmodic dysphonia). The researchers use a novel approach of combined imaging genetics, next-generation DNA sequencing, and clinical-behavioral testing. The use of a cross-disciplinary approach as a tool for the discovery of the mediating neural mechanisms that bridge the gap from DNA sequence to the pathophysiology of dystonia holds a promise for the understanding of the mechanistic aspects of brain function affected by risk gene variants, which can be used reliably for the discovery of associated genes and neural integrity markers for this disorder. The expected outcome of this study may lead to better clinical management of this disorder, including its improved detection, accurate diagnosis, and assessment of the risk of developing dystonia in family members.

Primary Outcome

Identify imaging biomarker of laryngeal dystonia

Interventions

  • OTHER MRI
  • PROCEDURE Blood draw

Study Locations (1)

Massachusetts

  • Massachusetts Eye and Ear Infirmary - Boston

Trial Details

FieldValue
Enrollment Target 410 participants
Start Date 2017-01-23
Est. Completion 2028-07-31
Kristina Simonyan

5 total trials

What NCT03042975 shows while recruiting

NCT03042975 is an observational study that tracks outcomes without assigning an intervention. The registered 410 participants enrollment target is mid-sized for trials with a published cap, above the 64-participant average among 9 other Laryngeal Dystonia trials with a reported enrollment target (541% higher).

The record links to 4 conditions, with Laryngeal Dystonia appearing as the primary indexed condition, and to 2 interventions - of which MRI is the first listed.

NCT03042975 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03042975 about?

NCT03042975 is a clinical study titled "Imaging Genetics of Laryngeal Dystonia". The contribution of genetic risk factors to the development of focal dystonias is evident. However, understanding of how variations in the causative gene expression lead to variations in brain abnormalities in different phenotypes of dystonia (e.g., familial, sporadic) remains limited. The research ...

What is the current status of trial NCT03042975?

This trial is currently recruiting. The enrollment target is 410 participants. The study started on 2017-01-23. Estimated completion is 2028-07-31.

What conditions does trial NCT03042975 study?

This clinical trial studies the following conditions: Laryngeal Dystonia, Muscle Tension Dysphonia, Voice Tremor, Unaffected Relatives of Laryngeal Dystonia Patients.

What interventions are being tested in trial NCT03042975?

The interventions under investigation include: MRI (OTHER), Blood draw (PROCEDURE).

Who is sponsoring clinical trial NCT03042975?

This trial is sponsored by Kristina Simonyan, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03042975 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Laryngeal Dystonia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03042975's enrollment target sits among peer trials

410 1st of 9 higher than 9 of 9 other Laryngeal Dystonia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Laryngeal Dystonia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02043691 · 410 participants · NA

    Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies

  • NCT05730036 · 410 participants · Phase 3

    A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

  • NCT05751473 · 410 participants · NA

    Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers

  • NCT06064877 · 410 participants · Phase 3

    A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03042975, the US trial registry maintained by the National Library of Medicine. NCT03042975 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.